Cita APA (7a ed.)

Nedosugova, L. V., Petunina, N. A., & Galstyan, K. O. (2014). Initial investigation of efficacy and safety of a new dipeptidyl peptidase-4 inhibitor, gosogliptin, for type 2 diabetes in Russia. Endocrinology Research Centre.

Cita Chicago Style (17a ed.)

Nedosugova, Lyudmila Viktorovna, Nina Alexandrovna Petunina, y Karina Oganesovna Galstyan. Initial Investigation of Efficacy and Safety of a New Dipeptidyl Peptidase-4 Inhibitor, Gosogliptin, for Type 2 Diabetes in Russia. Endocrinology Research Centre, 2014.

Cita MLA (8a ed.)

Nedosugova, Lyudmila Viktorovna, et al. Initial Investigation of Efficacy and Safety of a New Dipeptidyl Peptidase-4 Inhibitor, Gosogliptin, for Type 2 Diabetes in Russia. Endocrinology Research Centre, 2014.